Whole-body imaging of thallium-201 after six different stress regimens
- PMID: 8113888
Whole-body imaging of thallium-201 after six different stress regimens
Abstract
There are a number of stress techniques in common use for 201Tl myocardial imaging but few studies have been performed comparing the biodistribution of 201Tl in each case.
Methods: We studied 36 normal patients after six different stress regimens by whole-body imaging, 40 min after 201Tl injection. The stress regimens were exercise, dipyridamole, adenosine or dobutamine alone in standard doses and exercise combined with a vasodilator (dipyridamole or adenosine).
Results: Cardiac uptake expressed as a percentage of whole body uptake was greater for the vasodilators compared with exercise (p < 0.005), and this difference was unaffected by combining either vasodilator with exercise. Intermediate results were found with dobutamine. Heart-to-liver (p < 0.01) and abdomen (p < 0.05) ratios were greater for exercise compared with the vasodilators, and this difference was also unaffected by combining the exercise with either vasodilator. Heart-to-lung ratios were highest with any stress involving exercise (p < 0.05). The heart-to-background ratios with dobutamine were similar to the vasodilators.
Conclusion: Vasodilator infusion yields higher cardiac 201Tl uptake than exercise, but when given alone this results in poor heart-to-background ratios. Combining either vasodilator with exercise maintains the high cardiac uptake, but substantially improves the heart-to-background ratios to levels similar to exercise alone. Dobutamine stress produces an intermediate cardiac uptake, and heart-to-background ratios similar to the vasodilators. Therefore, optimal imaging conditions are obtained by stress which combines a vasodilator with exercise.
Similar articles
-
Comparison between dipyridamole and adenosine as pharmacologic coronary vasodilators in detection of coronary artery disease with thallium 201 imaging.J Nucl Cardiol. 1996 May-Jun;3(3):204-11. doi: 10.1016/s1071-3581(96)90034-3. J Nucl Cardiol. 1996. PMID: 8805740 Clinical Trial.
-
Biokinetics of thallium-201 in normal subjects: comparison between adenosine, dipyridamole, dobutamine and exercise.J Nucl Med. 1994 Apr;35(4):535-41. J Nucl Med. 1994. PMID: 8151371
-
Myocardial perfusion imaging during pharmacologic stress testing.Cardiol Clin. 1994 May;12(2):223-45. Cardiol Clin. 1994. PMID: 8033174 Review.
-
The VEX-test for myocardial scintigraphy with thallium-201 and sestamibi: effect on abdominal background activity.J Nucl Med. 1995 Jun;36(6):914-20. J Nucl Med. 1995. PMID: 7769446
-
Comparison of pharmacologic stress agents.J Nucl Cardiol. 1996 Nov-Dec;3(6 Pt 2):S22-6. doi: 10.1016/s1071-3581(96)90204-4. J Nucl Cardiol. 1996. PMID: 8989683 Review.
Cited by
-
Exercise supplementation to dipyridamole prevents hypotension, improves electrocardiogram sensitivity, and increases heart-to-liver activity ratio on Tc-99m sestamibi imaging.J Nucl Cardiol. 2001 Nov-Dec;8(6):652-9. doi: 10.1067/mnc.2001.117204. J Nucl Cardiol. 2001. PMID: 11725261 Clinical Trial.
-
Treadmill exercise during adenosine infusion is safe, results in fewer adverse reactions, and improves myocardial perfusion image quality.J Nucl Cardiol. 2000 Sep-Oct;7(5):439-46. doi: 10.1067/mnc.2000.108030. J Nucl Cardiol. 2000. PMID: 11083192 Clinical Trial.
-
What is the current status of quantification and nuclear medicine in cardiology?Eur J Nucl Med. 1996 Jul;23(7):815-51. doi: 10.1007/BF00843713. Eur J Nucl Med. 1996. PMID: 8662122 Review. No abstract available.
-
Impact of an abbreviated adenosine protocol incorporating adjunctive treadmill exercise on adverse effects and image quality in patients undergoing stress myocardial perfusion imaging.J Nucl Cardiol. 2000 Nov-Dec;7(6):584-9. doi: 10.1067/mnc.2000.108737. J Nucl Cardiol. 2000. PMID: 11144473
-
Comparison between dipyridamole and adenosine as pharmacologic coronary vasodilators in detection of coronary artery disease with thallium 201 imaging.J Nucl Cardiol. 1996 May-Jun;3(3):204-11. doi: 10.1016/s1071-3581(96)90034-3. J Nucl Cardiol. 1996. PMID: 8805740 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources